This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
EV-302
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SES AUA 2025
Thought Leaders 2025
APCCC Diagnostics 2025
ASCO GU 2025
SUO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Video Lectures
ASCO GU 2025 Videos
Immune Infiltration Gene Signatures Predict Response to Gemcitabine Docetaxel vs BCG in Bladder Cancer - Michael O'Donnell
March 14, 2025
Details
Safety of Combining Radiotherapy with Antibody Drug Conjugates in Advanced Urothelial Carcinoma - Neil Desai
March 14, 2025
Details
Circulating and Urinary Tumor DNA in Bladder Cancer Treatment and Surveillance - Alan Tan
March 14, 2025
Details
COSMIC-313 Trial for Advanced Renal Cell Carcinoma - Laurence Albiges
March 13, 2025
Details
Mucoadhesive Gemcitabine Formulation for Upper Tract Urothelial Carcinoma - Marie-Pier St-Laurent
March 12, 2025
Details
Cardiovascular Management in Advanced Prostate Cancer - Zeynep Irem Ozay
March 12, 2025
Details
Cretostimogene Expanded Access Program for BCG-Unresponsive Bladder Cancer - Sarah Psutka
March 12, 2025
Details
TROPION-PanTumor01 Trial for Advanced Bladder Cancer - Funda Meric-Bernstam
March 11, 2025
Details
Germline Testing for Risk Stratification in Low-Grade Bladder Cancer on Active Surveillance - Roberto Contieri
March 11, 2025
Details
Bladder Cancer Risk Stratification Using Non-Coding RNA - Yair Lotan
March 11, 2025
Details
Genomic Characterization of Young-Onset Bladder Cancer - Alina Basnet
March 11, 2025
Details
EMBARK Trial Subanalysis for High-Risk Biochemical Recurrent Prostate Cancer - Stephen Freedland
March 10, 2025
Details
Estrogen Patches Combined with AR Pathway Inhibitors Show Promise in Prostate Cancer Management - Nicholas James
March 10, 2025
Details
Real-World Safety Profiles of First-Line Therapies for Advanced Urothelial Carcinoma - Amanda Nizam
March 10, 2025
Details
Phase II Trial Results of Disitamab Vedotin and Toripalimab Combination for Muscle-Invasive Bladder Cancer - Xinan Sheng
March 10, 2025
Details
Combination Lenvatinib-Tislelizumab for Fumarate Hydratase-Deficient Renal Cell Carcinoma - Wen Kong
March 9, 2025
Details
Tumor Suppressor Gene Status Refines Prognosis and Treatment Selection in Metastatic Prostate Cancer - Martino Pedrani
March 8, 2025
Details
ctDNA as a Prognostic Biomarker in Bladder Cancer Treatment Decisions - Nimira Alimohamed
March 7, 2025
Details
Intravesical Antibody-Drug Conjugates for Bladder Cancer - Di Maria Jiang
March 6, 2025
Details
IMPLEMENT Study Reveals Barriers to Treatment Intensification in Metastatic Prostate Cancer - Stacy Loeb
March 6, 2025
Details
Radiation Therapy vs Surgery Outcomes in High-Risk Localized Prostate Cancer Patients - Soumyajit Roy
March 6, 2025
Details
CALYPSO Trial: Savolitinib and Durvalumab in Advanced Papillary Renal Cancer - Francesca Jackson-Spence
March 6, 2025
Details
Avelumab’s Survival Impact in Diabetic vs Non-Diabetic Bladder Cancer Patients - Shilpa Gupta
March 5, 2025
Details
CheckMate 274 Analysis Shows Improved Outcomes for Bladder Cancer Patients with Adjuvant Nivolumab - Matthew Galsky
March 5, 2025
Details
Underutilization of Genomic Testing in Metastatic Castration-Resistant Prostate Cancer - Pedro Barata
March 5, 2025
Details
Advances in Non-Muscle Invasive Bladder Cancer Treatment Options - Bogdana Schmidt
March 4, 2025
Details
RETAIN-2 Study Shows Promise for Bladder Cancer Preservation - Pooja Ghatalia
March 4, 2025
Details
Global BCG Shortage Impacts Treatment for High-Risk Bladder Cancer Patients - Jens Bedke
March 4, 2025
Details
Lutetium PSMA Therapy in mCRPC: Real-World Evidence from PRECISION Data Platform - Oliver Sartor
March 4, 2025
Details
Registry Data Shows Risk Migration With Blue Light Cystoscopy - Alireza Ghoreifi & Siamak Daneshmand
March 3, 2025
Details
Metastasis-Directed Therapy Improves Outcomes in Oligometastatic Prostate Cancer in WOLVERINE Study - Chad Tang
March 3, 2025
Details
COTRIMS Study: Reducing Long-Term Toxicity in Metastatic Seminoma Treatment - Axel Heidenreich
March 3, 2025
Details
177-Lutetium-PSMA vs Cabazitaxel: A Real-World mCRPC Study - Mike Wenzel
March 3, 2025
Details
Gut Microbiome and Prostate Cancer: How Diet Impacts Disease Progression - Robert Thomas
February 28, 2025
Details
The NIAGARA Trial Highlights the Role of Durvalumab in Bladder Cancer Treatment - Matthew Galsky
February 28, 2025
Details
Micropapillary Histology in Bladder Cancer: A Retrospective Survival Analysis - Muhammad Alkazemi & Hikmat Al-Ahmadie
February 28, 2025
Details
KEYMAKER-U03 Trial: Combinatorial Therapies for IO-Refractory Kidney Cancer - Kathryn Beckermann
February 28, 2025
Details
ACCEL Trial Tests Actinium-225-PSMA-62 in Prostate Cancer - Ramy Saleh
February 27, 2025
Details
Real-World Trends in Bone Health Agent Use for Metastatic Prostate Cancer - Umang Swami
February 27, 2025
Details
REDUSE Trial: Comparing Denosumab Dosing Intervals in mCRPC - Arnoud Templeton
February 27, 2025
Details
Patient-Level Data Confirms ARPI Value in mHSPC Treatment in Meta-Analysis - David Fisher
February 27, 2025
Details
PORTOS Biomarker Guides Radiation Dose Escalation in Prostate Cancer Treatment - George Zhao & Alan Dal Pra
February 27, 2025
Details
Darolutamide Monotherapy in Prostate Cancer: A Phase II Trial Overview - Xin Gao
February 26, 2025
Details
Exploring Actinium-225 in PSMA-Targeted Therapy for Prostate Cancer - Michael Morris
February 26, 2025
Details
Real-World Treatment Patterns in Advanced Prostate Cancer from PRECISION Data Platform - Oliver Sartor
February 26, 2025
Details
ARASTEP Trial Tests Darolutamide and ADT in High-Risk Biochemically Recurrent Prostate Cancer - Alicia Morgans
February 25, 2025
Details
Combining Genomic Classifier and Digital Pathology Artificial Intelligence in Prostate Cancer Risk Stratification - Daniel Spratt
February 25, 2025
Details
Talazoparib Improves Survival in HRR-Mutated mCRPC Patients in TALAPRO-2 Trial - Karim Fizazi
February 25, 2025
Details
Dual Immune Activation with EG-70 Targets Non-Muscle Invasive Bladder Cancer - Vikram Narayan
February 25, 2025
Details
Enfortumab Vedotin and Pembrolizumab Demonstrate Durable Responses in Advanced Bladder Cancer - Thomas Powles
February 24, 2025
Details
ARANOTE Trial Explores Darolutamide’s Role in High and Low-Volume Metastatic Prostate Cancer - Fred Saad
February 24, 2025
Details
ABLE-32 Trial Explores Nadofaragene Firadenovec for Intermediate-Risk NMIBC - Neal Shore
February 22, 2025
Details
Real-World Data on Nadofarogene Firadenovec for BCG-Unresponsive Bladder Cancer - Mark Tyson & Jacob Moyer
February 20, 2025
Details
Genomic Classifier Decipher® Guides Treatment Intensification in Post-Prostatectomy Patients - Phuoc Tran
February 13, 2025
Details
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
